The Biotech Deck Drinking Game
10 Slides You'll Always See
If you've been pitched by more than three biotech startups in
The Pivot Paradox
Why constant reinvention is both vital—and a sign you may have no idea what you're doing
Once
Global Pharma & Biotech M&A (Mar–Jun 2025): Deals, Drivers & Trends
The second quarter of 2025 saw a surge in mergers and acquisitions (M&A) within the pharmaceutical and biotechnology
From Tricorders to Tribbles: When Sci-Fi Becomes a Patent Filing
It is a truth almost universally acknowledged—except, perhaps, in FDA review meetings—that no credible scientist gets funded anymore
The shape of cures to come: AlphaFold’s structural revolution in drug discovery
The decades-long puzzle of protein folding
In the pantheon of scientific challenges, few have loomed as large or as stubborn
No Cure Without Coverage: Digital Health’s Reimbursement Riddle
When a small Berlin startup launched an obesity therapy app a few years ago, investors hailed it as a potential
Real-World Data (RWD): The Messy Yet Essential Future of Healthcare
Real-World Data (RWD) is the equivalent of field notes in anthropology: messy, unstructured, but full of valuable insights about how
Of CEOs, Titles, and Other Startup Ailments: A Treatise on the Cult of Empty Authority
Startups are curious beasts. They move fast, break things, raise millions, and yet remain spectacularly unable to define who is
The Biotech Platform Company Model: De-Risking Drug Development or VC Mirage?
Introduction: Platforms, Promise, and the VC Paradox
Biotechnology has always been a high-stakes endeavor, with the odds stacked against any
The Dusty Tools of Management: Why We Still Cling to Outdated Frameworks
If you’ve been through business school, corporate training, or an executive retreat, chances are you’ve encountered the holy